Karam Turath Tawfeeq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Karam Turath Tawfeeq has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Hany Akeel Al-Hussaniy
Department of Pharmacology, College of Pharmacy, Al-nisour University, Baghdad, Iraq
2 shared publications - Ali Hikmat Alburghaif
Department of Pharmaceutical Chemistry, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
1 shared publication Ghufran Zuhair Zuhair
Department Community and Family Medicine, University of Baghdad / College of Medicine, Iraq
1 shared publication- Meena Akeel Naji
Department of family Physicians, College of Medicine, University of Baghdad, Baghdad, Iraq
1 shared publication
Latest Publications
- Open Access
- 12 January 2026
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 38 (4) , 213
ABO blood types as a risk factor for severe symptoms of COVID-19 infection
Numerous studies have investigated whether the ABO blood group system influences susceptibility to SARS-CoV-2 infection and disease severity. The association between blood type and COVID-19 is thought to involve both genetic and environmental factors. The present study aimed to evaluate the relationship between ABO blood phenotypes and the severity of COVID-19 among Arab populations, with a particular focus on Iraqi patients. To assess the association between ABO blood phenotypes and the occurrence and severity of SARS-CoV-2 infection. A total of 731 patients with COVID-19 confirmed by a positive PCR test were included in the study. A control group consisted of healthy volunteers with negative PCR results and no clinical symptoms of COVID-19. In all participants, ABO blood phenotype was determined. In infected patients, disease severity and mortality were evaluated and analyzed in relation to blood group phenotype. Patients with blood group A demonstrated a higher risk of COVID-19 infection compared with non-A blood groups. In contrast, individuals with blood group O showed a significantly lower incidence of COVID-19 infection and reduced disease severity (odds ratio [OR] = 0.686; 95% confidence interval [CI]: 0.521-0.902). No statistically significant differences were observed for other blood groups. Among critically ill patients, blood group A was associated with a significantly higher mortality rate compared with non-A blood groups (OR = 3.341; 95% CI: 1.416-8.158). Blood group A is associated with an increased risk of severe COVID-19 manifestations, including pneumonia and mortality, whereas blood group O appears to confer a protective effect against severe disease.
- 12 January 2026
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 38 (4) , 213
Open AccessABO blood types as a risk factor for severe symptoms of COVID-19 infection
Numerous studies have investigated whether the ABO blood group system influences susceptibility to SARS-CoV-2 infection and disease severity. The association between blood type and COVID-19 is thought to involve both genetic and environmental factors. The present study aimed to evaluate the relationship between ABO blood phenotypes and the severity of COVID-19 among Arab populations, with a particular focus on Iraqi patients. To assess the association between ABO blood phenotypes and the occurrence and severity of SARS-CoV-2 infection. A total of 731 patients with COVID-19 confirmed by a positive PCR test were included in the study. A control group consisted of healthy volunteers with negative PCR results and no clinical symptoms of COVID-19. In all participants, ABO blood phenotype was determined. In infected patients, disease severity and mortality were evaluated and analyzed in relation to blood group phenotype. Patients with blood group A demonstrated a higher risk of COVID-19 infection compared with non-A blood groups. In contrast, individuals with blood group O showed a significantly lower incidence of COVID-19 infection and reduced disease severity (odds ratio [OR] = 0.686; 95% confidence interval [CI]: 0.521-0.902). No statistically significant differences were observed for other blood groups. Among critically ill patients, blood group A was associated with a significantly higher mortality rate compared with non-A blood groups (OR = 3.341; 95% CI: 1.416-8.158). Blood group A is associated with an increased risk of severe COVID-19 manifestations, including pneumonia and mortality, whereas blood group O appears to confer a protective effect against severe disease.
- Open Access
- 1 January 2022
- Published by Iraqi Medical Research Center in Medical and Pharmaceutical Journal
- Vol. 1 (2) , 24-33
Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication
Background: Due to its negative effects on the unborn child and the mother as a consumer, pregnant women's intake of psychoactive substances has become a public health concern. Additionally, consuming these chemicals has been linked to several neurological development changes in children, including behavioral issues (such as attention deficit hyperactivity disorder and autism spectrum disorder), cognitive issues, and sensory and motor function changes. Objectives: To perform a thorough, comprehensive study of the neurodevelopmental problems in children linked to maternal drug use. Method: A search of the scientific literature on studies about neurodevelopmental abnormalities linked to maternal use of psychoactive medications during pregnancy and published in the previous ten years up to June 2022 was conducted from PubMed, Google Scholar, and Directory open access Journals. Results: The initial screening identified 380 articles. We excluded 50 unaccessible articles and 160 articles due to publication dates and study types; after that, 62 articles were also discarded because they were duplicates, and 68 were excluded because the information was irrelevant or systemic reviews, so we finally obtained 40 articles for full-text reading distributed as follows: 18 from PubMed, 12 from Directory Open Access Journal, and 10 from Google scholar
- 1 January 2022
- Published by Iraqi Medical Research Center in Medical and Pharmaceutical Journal
- Vol. 1 (2) , 24-33
Open AccessNeurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication
Background: Due to its negative effects on the unborn child and the mother as a consumer, pregnant women's intake of psychoactive substances has become a public health concern. Additionally, consuming these chemicals has been linked to several neurological development changes in children, including behavioral issues (such as attention deficit hyperactivity disorder and autism spectrum disorder), cognitive issues, and sensory and motor function changes. Objectives: To perform a thorough, comprehensive study of the neurodevelopmental problems in children linked to maternal drug use. Method: A search of the scientific literature on studies about neurodevelopmental abnormalities linked to maternal use of psychoactive medications during pregnancy and published in the previous ten years up to June 2022 was conducted from PubMed, Google Scholar, and Directory open access Journals. Results: The initial screening identified 380 articles. We excluded 50 unaccessible articles and 160 articles due to publication dates and study types; after that, 62 articles were also discarded because they were duplicates, and 68 were excluded because the information was irrelevant or systemic reviews, so we finally obtained 40 articles for full-text reading distributed as follows: 18 from PubMed, 12 from Directory Open Access Journal, and 10 from Google scholar